Prostate cancer treatment - China's perspective

Area of Science:

• Oncology
• Epidemiology
• Public Health

Background:

• Prostate cancer (PCa) incidence and mortality are increasing in China.
• Chinese PCa patients exhibit unique epidemiological traits, including a low but rising incidence and a poorer but improving prognosis.
• Distinctive features characterize the current PCa treatment landscape in China.

Purpose of the Study:

• To review the epidemiological status of PCa in China.
• To analyze differences in treatment modalities for Chinese PCa patients.
• To explore socioeconomic and biological factors influencing PCa diversity and propose future treatment optimization strategies.

Main Methods:

• Literature review of epidemiological data on prostate cancer in China.
• Analysis of current prostate cancer treatment modalities employed in China.
• Discussion of socioeconomic and biological factors impacting prostate cancer presentation and outcomes.

Main Results:

• Significant increase in prostate cancer incidence and mortality in China.
• Identification of unique epidemiological characteristics in the Chinese PCa population.
• Distinctive treatment patterns observed within China, influenced by various factors.

Conclusions:

• A comprehensive understanding of Chinese PCa patient characteristics is essential for advancing treatment strategies.
• Socioeconomic and biological factors play a significant role in the diversity of PCa in China.
• Future efforts should focus on optimizing PCa treatment by addressing these specific Chinese population characteristics.